Ryan Preblick
Director of Finance/CFO en INDIVIOR PLC .
Fortuna: 1 M $ al 31/03/2024
Cargos activos de Ryan Preblick
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
INDIVIOR PLC | Director of Finance/CFO | 29/06/2020 | - |
Director/Board Member | 20/11/2020 | - | |
Comptroller/Controller/Auditor | 01/01/2012 | 01/01/2020 | |
Corporate Officer/Principal | 01/01/2020 | 29/06/2020 | |
OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | - | - |
Corporate Secretary | - | - | |
Treasurer | - | - |
Historial de carrera de Ryan Preblick
Formación de Ryan Preblick.
The Pennsylvania State University | Undergraduate Degree |
University of Richmond | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Director of Finance/CFO | 2 |
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
INDIVIOR PLC | Health Technology |
Empresas privadas | 1 |
---|---|
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Bolsa de valores
- Insiders
- Ryan Preblick
- Experiencia